Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1007/s10340-008-0213-1

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Gender and Location of CRC in IBDImplications for

Authors: Kwah Joann Ditelberg Jeremy S Farraye Francis A
Publish Date: 2013/03/01
Volume: 19, Issue: 3, Pages: E44-E46
PDF Link

Abstract

Patients with longstanding and extensive ulcerative colitis UC and Crohns disease of the colon have an increased risk of developing colorectal cancer CRC A metaanalysis published in 2001 including 116 studies from around the world reported the risk of CRC in patients with UC as 2 after 10 years 8 after 20 years and 18 after 30 years of disease1 Data from a 30year prospective surveillance program in the UK published in 2004 reported a lower risk of CRC in patients with UC of 25 at 20 years 76 at 30 years and 108 at 40 years2 While this suggests that the risk of developing CRC is lower than previously thought CRC is still a significant concern for patients with UC

Keywords:

References

citation title=Progression of lowgrade dysplasia in ulcerative colitis effect of colonic location citation journal title=Gastrointest Endosc citation year=2011 citation volume=74 citation pages=10871093

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  2. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  3. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  4. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  5. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  6. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  7. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  8. Role of diet in the development of inflammatory bowel disease
  9. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  10. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  13. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  14. Babesiosis in a Patient on Infliximab for Crohn's Disease
  15. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  16. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  17. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  18. What is the incidence, prevalence, and natural history of indeterminate colitis?
  19. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  20. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  21. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  22. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis
  23. Dangers associated with endoscopic management of strictures in IBD
  24. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  25. Role of the interleukin 24 in patients with ulcerative colitis
  26. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  27. Nitric Oxide and Colitis: Rats, Humans and Now Macaques
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease
Search Result: